Related Experiment Video
Updated: Sep 28, 2025

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Aristolochic acid: What urologists should know
Mohanarangam Thangavelu1, Asmaa Ismail2, Ahmed Zakaria3
1Northern Ontario School of Medicine, Thunder Bay, Ontario. drtmohan@googlemail.com.
Abstract:
To the Editor, Aristolochic acid is one of major causes for upper tract urothelial carcinoma, especially in younger population. While it is mentioned as a cause in guidelines, little is actually known about the toxin by urologists. We are aiming in our letter to provide some direct and clear information to ourselves that would help us to know more about that toxin and how it can adversely affect our patients [...].
Insights
Aristolochic acid is a significant cause of upper tract urothelial carcinoma, particularly in younger individuals. This letter aims to clarify information about this toxin for urologists to better understand its adverse effects on patients.
Area of Science:
- Toxicology
- Urology
- Oncology
Background:
- Aristolochic acid is a known etiological factor for upper tract urothelial carcinoma (UTUC).
- Despite its recognition in clinical guidelines, detailed knowledge of aristolochic acid among urologists remains limited.
- Understanding the toxin is crucial for managing UTUC, especially in younger patients.
Purpose of the Study:
- To provide urologists with clear and direct information regarding aristolochic acid.
- To enhance the understanding of how aristolochic acid adversely affects patients with UTUC.
- To bridge the knowledge gap concerning this specific toxin in clinical practice.
Main Methods:
- Literature review and synthesis of existing data on aristolochic acid.
- Focus on toxicological mechanisms and clinical manifestations.
- Information compilation for educational purposes.
Main Results:
- Aristolochic acid is a potent nephrotoxin and carcinogen.
- It is implicated in a subset of UTUC cases, often presenting in younger demographics.
- Mechanisms of action involve DNA adduct formation and subsequent mutations.
Conclusions:
- Increased awareness and knowledge of aristolochic acid are necessary for urologists.
- This understanding can lead to improved patient diagnosis and management strategies for UTUC.
- Further research into the long-term effects and specific patient populations affected is warranted.
Related Concept Videos
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Urinary Tract Calculi III: Medical Management
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:

